J&J/Cordis' Heparin-Coated Stent Product Launch Scheduled For Early 2001
This article was originally published in The Gray Sheet
Executive Summary
Cordis Cardiology will begin shipments of its Bx Velocity coronary stent with HepaCoat on Nov. 20, according to the Johnson & Johnson subsidiary.